{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:efpegerglucagon [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:perenostobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ifinatamab deruxtecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03860038: Phase 2 Interventional Active, not recruiting Multiple Myeloma in Relapse
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03647800: Phase 1 Interventional Unknown status AML
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:xaluritamig [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:gresonitamab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00004806: Phase 1 Interventional Completed Cystic Fibrosis
(1995)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04209114: Phase 3 Interventional Completed Bladder Cancer
(2020)
Source URL:
Class:
PROTEIN
